rethinkTHC Search
Menu
Study breakdown

Systematic review found medical cannabis may benefit some fibromyalgia patients with mild side effects

Systematic ReviewModerate evidence
The takeaway

A systematic review of 10 studies (1,136 patients) found medical cannabis was generally safe and well-tolerated for fibromyalgia, with no serious adverse events reported.

Fibromyalgia patients and rheumatologists considering cannabis as a treatment option.

No serious adverse events across 1,136 patients in 10 studies

What the researchers found

Across 3 RCTs and 6 observational studies, cannabis showed potential benefit for fibromyalgia symptoms with side effects limited to feeling "high," dizziness, dry mouth, cough, red eyes, and drowsiness. No serious adverse events were reported. The review could not identify which specific cannabis type or formulation was most effective.

Why it matters

Fibromyalgia remains poorly treated by conventional medicine. This review confirms that medical cannabis has a favorable safety profile in this population, which is important given that many fibromyalgia patients are already using cannabis without clinical guidance.

The numbers in context

181 citations screened, 10 included. 1,136 patients total. 3 RCTs, 6 observational, 1 comparison study. Study sizes: 9-383 patients (mean 114, median 36). Adverse events: mild only, no serious events.

How the study worked

Systematic review searching MEDLINE, Embase, CINAHL, AMED, Scopus, and Cochrane CENTRAL (2000-2020). 10 of 181 identified studies met inclusion criteria. Total of 1,136 patients across all studies (intervention n=945, control n=108, crossover n=83).

What this study cannot tell us

Only 10 studies, mostly observational. Heterogeneous study designs. Small sample sizes. Cannot determine optimal cannabis type, dose, or duration. Three different study designs limit synthesis.

How to read the evidence

Systematic methodology but limited by few studies, small samples, and heterogeneous designs.

When this study was published

2021 systematic review covering studies from 2000-2020.

The bigger picture

The safety finding is arguably more important than the efficacy signal at this stage. For a chronic condition where patients are often desperate for relief, knowing that medical cannabis has mild and manageable side effects allows for more informed shared decision-making.

Questions still open

  • Which cannabis formulation is most effective for fibromyalgia? What is the optimal dosing strategy? How does cannabis compare head-to-head with approved fibromyalgia drugs?

Common questions

Is medical cannabis safe for fibromyalgia?
Based on this review, medical cannabis appears safe with only mild side effects (dizziness, dry mouth, drowsiness). No serious adverse events were reported across 1,136 patients in 10 studies.
Does cannabis cure fibromyalgia?
No. The review found cannabis may help manage symptoms but could not establish definitive efficacy. More research is needed on which types and doses work best.

Read the original research

Safety and Efficacy of Medicinal Cannabis in the Treatment of Fibromyalgia: A Systematic Review.

Journal of alternative and complementary medicine (New York, N.Y.), 27(3), 198-213

Citation

Kurlyandchik, Inna; Tiralongo, Evelin; Schloss, Janet. (2021). Safety and Efficacy of Medicinal Cannabis in the Treatment of Fibromyalgia: A Systematic Review.. Journal of alternative and complementary medicine (New York, N.Y.), 27(3), 198-213. https://doi.org/10.1089/acm.2020.0331

Explore the wider topic